Association of Interleukin-17F Polymorphism and Mortality Predictors with the Risk of COVID-19

Table 1

Demographic data and associated comorbidities of the study COVID-19 cases (n = 132)

Variable n (%), median (25th–75th percentile)	COVID-19 patients total (n = 132)	Survivors (n = 75)	Non-survivors (n = 57)	P
Age (years)	65 (49.3–71)	57 (44–68)	69 (60–76)	<0.001
Sex
Female	76 (57.6)	45 (60)	31 (54.4)	0.518
Male	56 (42.4)	30 (40)	26 (45.6)
Associated comorbidities
<2	35 (26.5)	25 (33.3)	10 (17.5)	0.042
≥2	97 (73.5)	50 (66.7)	47 (82.5)
Diabetes mellitus	86 (65.2)	52 (69.3)	34 (59.6)	0.247
Systemic hypertension	95 (72)	47 (62.7)	48 (84.2)	0.006